Recent studies have shown several potential mechanisms related to the antiproliferative impact of RSV on lung cancer cells, including the binding of RSV to the Akt protein and destruction of the intracellular antioxidant pool in cells, in addition to the activation of the NGFR-AMPK-mTOR pathway [62,63,64,65]. Here, AKT1 is linked to lung carcinoma.